Latest News and Press Releases
Want to stay updated on the latest news?
-
Austin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Cellulite Treatment Market Size & Growth Outlook As per S&S Insider Research, the global Cellulite Treatment Market was valued at USD 2.30 billion...
-
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and...
-
Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK...
-
SAN FRANCISCO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- On September 4, 2025, investors in America’s Car-Mart, Inc. (NASDAQ: CRMT) saw the price of their shares crater over $8 (-18%) after the company...
-
Inside information: Carl Haglund appointed as CEO of KH Group Plc
-
Vancouver, Canada, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
-
Ottawa, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Flexible packages are the ones made from elastic—flexible materials which are easily formed after filling them with a product. The main material used in...
-
Ra’anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today...
-
Updated business plan, expanded management team, and upcoming R&D and manufacturing initiatives position the Company for accelerated global growth. Boca Raton, FL, Sept. 19, 2025 (GLOBE...
-
Lunsumio provides high and long-lasting response rates, with approximately two-thirds of patients with a complete response in remission after four years1Subcutaneous Lunsumio has potential to...